Obesity and endocrine disease.
Several endocrine abnormalities are reported in obesity. Some of these abnormalities are considered as causative factors for the development of obesity, whereas others are considered to be secondary effects of obesity and usually are restored after weight loss. Thyroid hormones usually are normal in obesity, with the exception of T3 which is elevated. Prolactin is normal but prolactin response to different stimuli is blunted. GH is low and GH response to stimuli is blunted. IGF-I levels are normal or elevated. Cortisol, ACTH, and urine free cortisol levels are usually normal; however, a hyperresponsiveness of the HPA axis with increased cortisol and ACTH response to stimulatory tests is observed in centrally obese individuals. Total testosterone and SHBG levels are low, but free testosterone levels are usually normal in obese men. LH and FSH levels usually are normal and estrogens are elevated. Norepinephrine levels are elevated, whereas epinephrine levels are low or normal. Aldosterone levels are elevated but renin activity is usually normal. Parathyroid hormone levels are elevated with normal serum calcium levels and increased urine calcium levels. Monogenic mutations that result in severe obesity have been described in several individuals. Also, several endocrine diseases have obesity as one their clinical manifestations. Hypothyroidism, Cushing's syndrome, GH and testosterone deficiency, polycystic ovarian syndrome, insulinoma, hypothalamic lesions, and genetic syndromes often present with obesity. In most of these conditions, appropriate treatment of the primary disease results in weight loss. In addition, the fat cell has been found to be an endocrine organ that produces several peptides that are bioactive and participate in the regulation of adipocyte function.
Kokkoris
Panagiotis
P
Division of Endocrinology, Diabetes, and Metabolism, Hellenic Air Force General Hospital, 3 P. Kanelopoulou Street, Athens 11525, Greece. pakokkoris@hotmail.com
Pi-Sunyer
F Xavier
FX
D000273:Adipose Tissue / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone; D000450:Aldosterone; D002395:Catecholamines; D004700:Endocrine System Diseases / Q000150:complications* / Q000503:physiopathology; D012739:Gonadal Steroid Hormones; D019382:Human Growth Hormone; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D009765:Obesity / Q000150:complications* / Q000503:physiopathology; D010281:Parathyroid Hormone; D011388:Prolactin; D012083:Renin; D013963:Thyroid Hormones
D002395:Catecholamines; D012739:Gonadal Steroid Hormones; D010281:Parathyroid Hormone; D013963:Thyroid Hormones; D019382:Human Growth Hormone; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D012083:Renin; D006854:Hydrocortisone